Distribution and Determinants of Metabolic Syndrome in Non-Obese Hypothyroid Patients
DOI:
https://doi.org/10.52783/jns.v14.2476Keywords:
Hypothyroidism, Metabolic syndrome, Dyslipidaemia, Cardiovascular riskAbstract
A number of metabolic and cardiovascular parameters may be profoundly impacted by hypothyroidism, a prevalent endocrine condition. The aim of this study was to determine the prevalence and risk factors of metabolic syndrome in hypothyroidism patients who are not overweight. This research lasted two years in a private medical college, Tamil Nadu between 2022 and 2024. Among 138 hypothyroidism patients the most significant group consisted of individuals from age 41 to 50 (28%). Females constituted majority (57%) of the study population. Hypertension was present in 32% of the patients, while diabetes mellitus was found in 29%. Elevated waist circumference was observed in 38% of the patients. High blood pressure was recorded in 22% of the patients. Regarding HbA1c levels, 55% had levels > 6.5%, indicating poor glycaemic control. While 38% of patients had total cholesterol levels over 200 mg/dL, 55% had triglyceride levels above 150 mg/dL. It was shown that 51% of the patients had low HDL levels (< 40 mg/dL) and 85% had high LDL levels (> 100 mg/dL), respectively. Patients with hypothyroidism are more likely to have metabolic and cardiovascular risk factors, according to this research. The need of doing thorough assessments and managing cardiovascular risk factors in this group is highlighted by these results. Regular monitoring and early intervention can help mitigate long-term risks associated with hypothyroidism.
Downloads
Metrics
References
Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 2018;20(2):12.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC., International Diabetes Federation Task Force on Epidemiology and Prevention. National Heart, Lung, and Blood Institute. American Heart Association (AHA). World Heart Federation. International Atherosclerosis Society. International Association for the Study of Obesity. Harmonising the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 Oct 20;120(16):1640-5.
Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014 Mar;43(1):1-23.
Strachan MWJ and Walker BR. Endocrine diseases in NA Boon, NR Colledge and BR Walker(eds), Davidson's Principle and practice of Medicine, 20th ed, Churchill Livingstone, New York, 2006: 739-804.
Grundy SM, Brewer B, Cleeman JI, Smith SC, Lenfant C. 'Definition of Metabolic syndrome', Proceedings of the National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues related to Definition. Circulation 2004; 109: 433-38.
Dhanraj E, Bhansali A, Jaggi S, Dutta P, Jain S, Tiwari P. Prevalence and predictors of metabolic syndrome in non-obese Asian Indians with newly detected type 2 diabetes mellitus. J Ind Med Assoc 2008; 106: 366-72.
Deshmukh V, Farishta F, Bhole M. Thyroid Dysfunction in Patients with Metabolic Syndrome: A Cross-Sectional, Epidemiological, Pan-India Study. International Journal of Endocrinology. 2018;2018(1):2930251.
Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014 Apr;94(2):355-82. doi: 10.1152/physrev.00030.2013. PMID: 24692351; PMCID: PMC4044302.
Pucci G, Alcidi R, Tap L, Battista F, Mattace-Raso F, Schillaci G. Sex- and gender-related prevalence, cardiovascular risk and therapeutic approach in metabolic syndrome: A review of the literature. Pharmacological Research. 2017 Jun 1;120:34–42.
Mehran L, Amouzegar A, Rahimabad PK, Tohidi M, Tahmasebinejad Z, Azizi F. Thyroid Function and Metabolic Syndrome: A Population-Based Thyroid Study. Horm Metab Res. 2017 Mar;49(3):192-200.
Hage M, Zantout MS, Azar ST. Thyroid Disorders and Diabetes Mellitus. J Thyroid Res. 2011 Jul 12;2011:439463.
Brenta G, Danzi S, Klein I. Potential therapeutic applications of thyroid hormone analogs. Nat Clin Pract Endocrinol Metab. 2007 Sep;3(9):632–40.
Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The Metabolic Syndrome. Endocr Rev. 2008 Dec;29(7):777–822.
Pazos-Moura CC, Moura EG, Breitenbach MM, et al. Nailfold capillaroscopy in hypothyroidism and hyperthyroidism: blood flow velocity during rest and postocclusive reactive hyperemia. Angiology 1998; 49: 471–476.
Lekakis J, Papamichael C, Alevizaki M, et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 1997; 7: 411–414
Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest. 2017 Jan 03;127(1):1-4.
Langén VL, Niiranen TJ, Puukka P, et al. Association of thyroid-stimulating hormone with lipid concentrations: an 11-year longitudinal study. Clin Endocrinol (Oxf) 2017; 86: 120–127.
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016 Jul 3;11:95–104.
Ogbonna S, Ezeani I, Okafor C, Chinenye S. Association between glycemic status and thyroid dysfunction in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes. 2019 Jul 12;12:1113–22.
Biondi B., Kahaly G.J., Robertson R.P. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr. Rev. 2019;40:789–824.
Bjergved L, Jørgensen T, Perrild H, Laurberg P, Krejbjerg A, Ovesen L, et al. Thyroid Function and Body Weight: A Community-Based Longitudinal Study. PLoS One. 2014 Apr 11;9(4):e93515.
Song R hua, Wang B, Yao Q ming, Li Q, Jia X, Zhang J an. The Impact of Obesity on Thyroid Autoimmunity and Dysfunction: A Systematic Review and Meta-Analysis. Front Immunol. 2019 Oct 1;10:2349.
Mottillo, S.; Filion, K.B.; Genest, J.; Joseph, L.; Pilote, L.; Poirier, P.; Rinfret, S.; Schiffrin, E.L.; Eisenberg, M.J. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010, 56, 1113–1132.
Rastgooye Haghi A, Solhjoo M, Tavakoli MH. Correlation Between Subclinical Hypothyroidism and Dyslipidemia. Iran J Pathol. 2017;12(2):106–11.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
